| Literature DB >> 26866722 |
Nobuhiko Okamoto1, Yasuhisa Toribe2, Keiko Shimojima3, Toshiyuki Yamamoto3.
Abstract
Tatton-Brown-Rahman syndrome is a new overgrowth syndrome due to DNMT3A (DNA cytosine 5 methyltransferase 3A) mutations. Mutation carriers show a distinctive facial appearance, intellectual disability, and increased height. We report a patient with overgrowth who showed submicroscopic deletion of chromosome 2p23 including DNMT3A. The deletion was detected by array-CGH. He showed moderate ID and distinctive facial gestalt. His clinical features were consistent with those of Tatton-Brown-Rahman syndrome. We suggest that 2p23 microdeletion including DNMT3A may cause similar symptoms in patients with DNMT3A mutations and should be considered in patients with overgrowth.Entities:
Keywords: DNMT3A; Tatton-Brown-Rahman syndrome; overgrowth syndrome
Mesh:
Substances:
Year: 2016 PMID: 26866722 DOI: 10.1002/ajmg.a.37588
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802